Filing Details

Accession Number:
0001420506-25-000363
Form Type:
13G Filing
Publication Date:
2025-02-12 19:00:00
Filed By:
Nine Ten Partners
Company:
Iradimed Corp (NASDAQ:IRMD)
Filing Date:
2025-02-13
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Nine Ten Capital Management 0 905,926 7.1%
Nine Ten Partners LP 0 905,926 7.1%
Russell Mollen 0 905,926 7.1%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Nine Ten Capital Management
 
Signature:Michelle Katauskas
Name/Title:CCO/CCO
Date:02/13/2025
 
Nine Ten Partners LP
 
Signature:Nine Ten Partners LP
Name/Title:LP
Date:02/13/2025
 
Russell Mollen
 
Signature:Russell Mollen
Name/Title:President
Date:02/13/2025